IMPLANT SITE VESICLES

This adverse event was reported 147 times

These drugs are most commonly taken by patients reporting IMPLANT SITE VESICLES:

# Drug Count
0 ETONOGESTREL 105
1 BACLOFEN INJECTION 6
2 HISTRELIN ACETATE 6
3 BACLOFEN 3
4 IBUPFROFEN 3
5 IBUPROFEN 3
6 IBUPROFEN 200 MG 3
7 IBUPROFEN 200MG 3
8 IBUPROFEN CAPSULE 3
9 IBUPROFEN CAPSULES 200 MG 3
See all common drugs associated with IMPLANT SITE VESICLES

IMPLANT SITE VESICLES is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Antiseptic [EPC] 2 0.0005
1 Progestin [EPC] 105 0.0004
2 Androgen [EPC] 3 0.0001
3 gamma-Aminobutyric Acid-ergic Agonist [EPC] 9 0.0001
4 Barbiturate [EPC] 1 0.0001
5 Glycopeptide Antibacterial [EPC] 3 0.0000
6 Amide Local Anesthetic [EPC] 3 0.0000
7 Antiarrhythmic [EPC] 3 0.0000
8 Ester Local Anesthetic [EPC] 1 0.0000
9 Central alpha-2 Adrenergic Agonist [EPC] 1 0.0000
See all drug classes enriched for association with IMPLANT SITE VESICLES